Substrate-Selective COX-2 Inhibition as a Novel Strategy for Therapeutic Endocannabinoid Augmentation
Trends in Pharmacological Sciences - Netherlands
doi 10.1016/j.tips.2014.04.006
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2014
Authors
Publisher
Elsevier BV